Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Mentis, M. J. Articles by Eidelberg, D. Search for Related Content PubMed Citation Articles by Mentis, M. J. Articles by Eidelberg, D. Depression Parkinson's Disease Cognition Neurodegeneration

Relationships Among the Metabolic Patterns That Correlate With Mnemonic, Visuospatial, and Mood Symptoms in Parkinson’s Disease

OBJECTIVE: A multivariate analysis of baseline brain metabolism was used to investigate the relationships among pathophysiological mechanisms responsible for cognitive dysfunction and dysphoria in nondemented patients with Parkinson’s disease. METHOD: Using [¹⁸F]fluorodeoxyglucose positron emission tomography and neuropsychological tests, the authors studied 15 nondemented patients who had Parkinson’s disease without major depression (DSM-III-R). Their mean age was 59.2 years (SD=9.2), the mean rating of Parkinson’s disease stage (Hoehn and Yahr scale) was 3.3 (SD=0.9), and all had Mini-Mental State Examination scores of 24 or higher. To identify specific regional patterns of brain metabolism associated with abnormal cognitive and mood functioning, the data were analyzed by using brain-behavior partial least squares. This multivariate voxel-based analysis allowed detection of significant topographic patterns of metabolic activity and quantification of the extent to which each topographic pattern correlated with scores on mnemonic, visuospatial, and dysphoric tests. RESULTS: Two significant, independent topographic patterns were identified. Pattern 1 included parieto-occipito-temporal and medial temporal brain regions, and pattern 2 included the lateral frontal and anterior limbic cortex. Patterns 1 and 2 exhibited a double dissociation in their behavioral correlates: pattern 1 correlated with both visuospatial and mnemonic functioning but not with dysphoria; pattern 2 correlated with dysphoria but not with the cognitive measures. CONCLUSIONS: The authors used the independence of topographic patterns and the size of correlations between topographic patterns and behavior to infer relationships among the pathophysiological processes responsible for the correlations. The finding that mildly abnormal mnemonic and visuospatial functioning correlated with the same topographic pattern suggests that a common pathophysiology underlies this marker of cognition in Parkinson’s disease. By contrast, the independence of the two topographic patterns supports the notion that different mechanisms underlie cognitive and dysphoric symptoms in nondemented patients with Parkinson’s disease.

This article has been cited by other articles:

				N. Abe, T. Fujii, K. Hirayama, A. Takeda, Y. Hosokai, T. Ishioka, Y. Nishio, K. Suzuki, Y. Itoyama, S. Takahashi, et al. Do parkinsonian patients have trouble telling lies? The neurobiological basis of deceptive behaviour Brain, May 1, 2009; 132(5): 1386 - 1395. [Abstract] [Full Text] [PDF]

				M. Vendette, J. -F. Gagnon, A. Decary, J. Massicotte-Marquez, R. B. Postuma, J. Doyon, M. Panisset, and J. Montplaisir REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia Neurology, November 6, 2007; 69(19): 1843 - 1849. [Abstract] [Full Text] [PDF]

				C. Huang, C. Tang, A. Feigin, M. Lesser, Y. Ma, M. Pourfar, V. Dhawan, and D. Eidelberg Changes in network activity with the progression of Parkinson's disease Brain, July 1, 2007; 130(7): 1834 - 1846. [Abstract] [Full Text] [PDF]

				D. Weintraub, D. Taraborelli, K. H. Morales, J. E. Duda, I. R. Katz, and M. B. Stern Escitalopram for Major Depression in Parkinson's Disease: An Open-Label, Flexible-Dosage Study J Neuropsychiatry Clin Neurosci, August 1, 2006; 18(3): 377 - 383. [Abstract] [Full Text] [PDF]

				K. Van Laere, C. Casteels, L. De Ceuninck, B. Vanbilloen, A. Maes, L. Mortelmans, W. Vandenberghe, A. Verbruggen, and R. Dom Dual-Tracer Dopamine Transporter and Perfusion SPECT in Differential Diagnosis of Parkinsonism Using Template-Based Discriminant Analysis J. Nucl. Med., March 1, 2006; 47(3): 384 - 392. [Abstract] [Full Text] [PDF]

				P. Remy, M. Doder, A. Lees, N. Turjanski, and D. Brooks Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system Brain, June 1, 2005; 128(6): 1314 - 1322. [Abstract] [Full Text] [PDF]

				D. Weintraub, A. B. Newberg, M. S. Cary, A. D. Siderowf, P. J. Moberg, G. Kleiner-Fisman, J. E. Duda, M. B. Stern, D. Mozley, and I. R. Katz Striatal Dopamine Transporter Imaging Correlates with Anxiety and Depression Symptoms in Parkinson's Disease J. Nucl. Med., February 1, 2005; 46(2): 227 - 232. [Abstract] [Full Text] [PDF]

				B. Ravina, D. Eidelberg, J. E. Ahlskog, R. L. Albin, D. J. Brooks, M. Carbon, V. Dhawan, A. Feigin, S. Fahn, M. Guttman, et al. The role of radiotracer imaging in Parkinson disease Neurology, January 25, 2005; 64(2): 208 - 215. [Abstract] [Full Text] [PDF]

				K. Van Laere, P. Santens, T. Bosman, J. De Reuck, L. Mortelmans, and R. Dierckx Statistical Parametric Mapping of 99mTc-ECD SPECT in Idiopathic Parkinson's Disease and Multiple System Atrophy with Predominant Parkinsonian Features: Correlation with Clinical Parameters J. Nucl. Med., June 1, 2004; 45(6): 933 - 942. [Abstract] [Full Text] [PDF]

				M. J. Mentis, V. Dhawan, T. Nakamura, M. F. Ghilardi, A. Feigin, C. Edwards, C. Ghez, and D. Eidelberg Enhancement of brain activation during trial-and-error sequence learning in early PD Neurology, February 25, 2003; 60(4): 612 - 619. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us